Stock listing
BOATS:IBIO iBio, Inc. Stock
US listing (BOATS) of iBio, Inc. · home listing NASDAQ:IBIO
Follow iBio, Inc. into a list and get an email when it puts out news.
Home listing price · NASDAQ:IBIO
$0.769 USD -0.045 (-5.5%)
Close on Oct 30, 2026 · This listing has no price on 6ix; the price shown is the home listing's, NASDAQ:IBIO
- Day range
- $0.740 – $0.811 USDOct 30, 2026
- Volume
- 213,524 sharesOct 30, 2026
- Market cap
- $49.43M USDAt the close on Oct 30, 2026 · price × 64.31M shares outstanding
- 52-week range
- $0.686 – $3.820 USDLowest and highest trades, Oct 31, 2025 – Oct 30, 2026
- Traded on an average day
- $822,358 USDMedian day 461,200 shares · last 3 months, Jul 30, 2026 – Oct 30, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:IBIO · Home | $0.769 USD | -0.045 (-5.5%) | 213,524 | $0.810 | $0.811 | $0.740 | $0.814 | Close on Oct 30, 2026 |
| Frankfurt:0JV0 | €0.677 EUR | +0.014 (+2.2%) | — | €0.677 | €0.677 | €0.677 | €0.662 | Close on Oct 30, 2026 |
Daily closes
Last 3 months, Jul 30, 2026 – Oct 30, 2026 · NASDAQ:IBIO · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $0.769 | -0.045 | -5.5% | $0.810 | $0.811 | $0.740 | 213,524 | |
| $0.814 | +0.009 | +1.2% | $0.819 | $0.830 | $0.777 | 247,599 | |
| $0.804 | +0.037 | +4.9% | $0.770 | $0.808 | $0.740 | 280,700 | |
| $0.767 | +0.060 | +8.5% | $0.707 | $0.774 | $0.690 | 474,565 | |
| $0.707 | -0.013 | -1.8% | $0.730 | $0.730 | $0.686 | 508,951 | |
| $0.720 | -0.060 | -7.7% | $0.770 | $0.780 | $0.710 | 653,900 | |
| $0.780 | -0.060 | -7.1% | $0.840 | $0.850 | $0.750 | 654,800 | |
| $0.840 | +0.020 | +2.4% | $0.840 | $0.880 | $0.840 | 517,900 | |
| $0.820 | +0.060 | +7.9% | $0.760 | $0.890 | $0.760 | 2,212,300 | |
| $0.760 | -0.010 | -1.3% | $0.760 | $0.780 | $0.750 | 354,100 | |
| $0.770 | -0.010 | -1.3% | $0.780 | $0.800 | $0.760 | 310,000 | |
| $0.780 | 0.000 | 0.0% | $0.750 | $0.820 | $0.750 | 348,500 | |
| $0.780 | 0.000 | 0.0% | $0.780 | $0.810 | $0.730 | 1,433,800 | |
| $0.780 | -0.120 | -13.3% | $0.900 | $0.900 | $0.770 | 1,343,700 | |
| $0.900 | +0.030 | +3.4% | $0.890 | $0.950 | $0.880 | 452,100 | |
| $0.870 | -0.050 | -5.4% | $0.920 | $0.970 | $0.850 | 1,642,000 | |
| $0.920 | -0.090 | -8.9% | $1.000 | $1.000 | $0.900 | 684,800 | |
| $1.010 | -0.040 | -3.8% | $1.050 | $1.060 | $0.970 | 2,707,900 | |
| $1.050 | -0.070 | -6.3% | $1.120 | $1.150 | $1.020 | 1,207,600 | |
| $1.120 | -0.010 | -0.9% | $1.140 | $1.180 | $1.080 | 1,126,100 | |
| $1.130 | +0.020 | +1.8% | $1.120 | $1.150 | $1.070 | 531,200 | |
| $1.110 | -0.070 | -5.9% | $1.180 | $1.210 | $1.100 | 337,900 | |
| $1.180 | +0.010 | +0.9% | $1.190 | $1.220 | $1.170 | 227,900 | |
| $1.170 | 0.000 | 0.0% | $1.200 | $1.200 | $1.160 | 234,300 | |
| $1.170 | -0.020 | -1.7% | $1.190 | $1.190 | $1.150 | 295,600 | |
| $1.190 | -0.010 | -0.8% | $1.230 | $1.240 | $1.150 | 617,600 | |
| $1.200 | -0.050 | -4.0% | $1.250 | $1.250 | $1.190 | 376,300 | |
| $1.250 | -0.080 | -6.0% | $1.320 | $1.350 | $1.240 | 363,700 | |
| $1.330 | +0.070 | +5.6% | $1.280 | $1.370 | $1.240 | 2,092,200 | |
| $1.260 | -0.020 | -1.6% | $1.290 | $1.310 | $1.260 | 385,500 | |
| $1.280 | +0.030 | +2.4% | $1.260 | $1.300 | $1.240 | 440,600 | |
| $1.250 | +0.070 | +5.9% | $1.250 | $1.310 | $1.210 | 2,090,500 | |
| $1.180 | -0.010 | -0.8% | $1.190 | $1.200 | $1.170 | 406,900 | |
| $1.190 | -0.010 | -0.8% | $1.200 | $1.220 | $1.170 | 375,800 | |
| $1.200 | -0.010 | -0.8% | $1.230 | $1.230 | $1.200 | 324,000 | |
| $1.210 | -0.020 | -1.6% | $1.240 | $1.240 | $1.200 | 184,800 | |
| $1.230 | -0.030 | -2.4% | $1.260 | $1.260 | $1.220 | 308,900 | |
| $1.260 | -0.040 | -3.1% | $1.300 | $1.300 | $1.250 | 404,600 | |
| $1.300 | -0.010 | -0.8% | $1.310 | $1.320 | $1.280 | 190,900 | |
| $1.310 | +0.010 | +0.8% | $1.290 | $1.330 | $1.280 | 265,400 | |
| $1.300 | -0.010 | -0.8% | $1.320 | $1.350 | $1.290 | 353,500 | |
| $1.310 | +0.050 | +4.0% | $1.260 | $1.340 | $1.260 | 310,700 | |
| $1.260 | -0.010 | -0.8% | $1.270 | $1.300 | $1.210 | 2,232,800 | |
| $1.270 | -0.090 | -6.6% | $1.370 | $1.370 | $1.250 | 875,800 | |
| $1.360 | -0.040 | -2.9% | $1.420 | $1.420 | $1.340 | 513,500 | |
| $1.400 | -0.030 | -2.1% | $1.430 | $1.460 | $1.400 | 374,500 | |
| $1.430 | -0.040 | -2.7% | $1.470 | $1.470 | $1.430 | 259,200 | |
| $1.470 | +0.050 | +3.5% | $1.410 | $1.480 | $1.410 | 436,011 | |
| $1.420 | -0.010 | -0.7% | $1.450 | $1.450 | $1.371 | 514,909 | |
| $1.430 | -0.040 | -2.7% | $1.460 | $1.500 | $1.420 | 754,700 | |
| $1.470 | -0.020 | -1.3% | $1.470 | $1.500 | $1.440 | 1,977,100 | |
| $1.490 | +0.040 | +2.8% | $1.470 | $1.500 | $1.420 | 839,400 | |
| $1.450 | 0.000 | 0.0% | $1.450 | $1.470 | $1.400 | 2,794,800 | |
| $1.450 | +0.020 | +1.4% | $1.450 | $1.480 | $1.420 | 589,300 | |
| $1.430 | +0.030 | +2.1% | $1.380 | $1.440 | $1.340 | 522,600 | |
| $1.400 | -0.070 | -4.8% | $1.480 | $1.480 | $1.380 | 507,500 | |
| $1.470 | 0.000 | 0.0% | $1.470 | $1.540 | $1.460 | 599,500 | |
| $1.470 | +0.070 | +5.0% | $1.410 | $1.510 | $1.370 | 375,000 | |
| $1.400 | -0.010 | -0.7% | $1.410 | $1.430 | $1.390 | 479,100 | |
| $1.410 | +0.020 | +1.4% | $1.400 | $1.430 | $1.380 | 436,300 | |
| $1.390 | -0.010 | -0.7% | $1.400 | $1.410 | $1.360 | 424,300 | |
| $1.400 | -0.060 | -4.1% | $1.460 | $1.480 | $1.390 | 304,700 | |
| $1.460 | +0.040 | +2.8% | $1.460 | $1.490 | $1.440 | 486,100 | |
| $1.420 | +0.020 | +1.4% | $1.440 | $1.440 | $1.380 | 470,300 | |
| $1.400 | +0.010 | +0.7% | $1.410 | $1.470 | $1.340 | 728,600 | |
| $1.390 | +0.030 | +2.2% | $1.360 | $1.420 | $1.350 | 422,300 |
- Ticker
- BOATS:IBIO
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- BOATS
- Currency
- USD
What changed lately
Latest news release · Oct 13, 2026
iBio Highlights Data from a Non-human Primate Study Supporting IBIO-610’s Potential to Preserve Muscle in Combination with GLP-1 Therapy
Latest deck · September 2026
Investor Presentation (September 2026)
Investor deck · 29 slides
Latest news
iBio Highlights Data from a Non-human Primate Study Supporting IBIO-610’s Potential to Preserve Muscle in Combination with GLP-1 Therapy
Oct 13, 2026
Closed $0.78 (-13.3%) on Oct 13, 2026
Impact Biomedical Inc Announces Filing of Form F-4 Registration Statement in Connection with Proposed Merger with Zoar Ltd. (f/k/a Dr. Ashley’s Limited)
Sep 16, 2026
Closed $1.18 (-0.8%) on Sep 16, 2026
iBio to Participate in the 2026 Wells Fargo Annual Healthcare Conference
Sep 1, 2026
Closed $1.31 (+4.0%) on Sep 2, 2026
iBio Reports Fiscal Year 2026 Financial Results and Provides Corporate Update
Aug 28, 2026
Closed $1.36 (-2.9%) on Aug 28, 2026
IntraBio’s Pivotal Phase III Trial in CACNA1A-Related Disorders Is Enrolling and Is Expected to Be Over-Enrolled and Complete Recruitment in October
Aug 19, 2026
Closed $1.49 (+2.8%) on Aug 19, 2026
iBio Strengthens Clinical Leadership with Appointment of Endocrinologist Molly Carr as Chief Medical Officer
Aug 4, 2026
Closed $1.46 (+2.8%) on Aug 4, 2026
IntraBio Announces Submission of Variation Application to the European Medicines Agency for AQNEURSA® for Ataxia-Telangiectasia
Jun 5, 2026
Closed $1.82 (-5.7%) on Jun 5, 2026
iBio to Participate in Upcoming Healthcare Investor Conferences
Jun 2, 2026
Closed $1.84 (+4.5%) on Jun 3, 2026
iBio Becomes a Clinical-Stage Company with First Participant Dosed in Phase 1 Clinical Trial of IBIO-600 in Adults with Obesity
Jun 2, 2026
Closed $1.76 (-6.9%) on Jun 2, 2026
iBio Reports Q3 Fiscal Year 2026 Financial Results and Provides Corporate Update
May 12, 2026
Closed $1.55 (-3.7%) on May 13, 2026
Decks
Investor Presentation (September 2026)
Investor deck · 29 slides · September 2026
Investor Presentation (March 2026)
Investor deck · 39 slides · Mar 9, 2026
Investor Presentation (August 2025)
Investor deck · 34 slides · Aug 18, 2025
Investor Presentation (June 2025)
Investor deck · 45 slides · Jun 24, 2025
iBio, Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 20 in the last 12 months · 115 in all · newest Oct 13, 2026 · oldest 2019
- Decks
- 20 decks · latest September 2026
Where iBio, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:IBIO · Home listing | NASDAQ | United States | USD |
| Tradegate:0JV0 | Tradegate | Germany | EUR |
| gettex:0JV0 | gettex | Germany | EUR |
| BOATS:IBIO · This page | BOATS | United States | USD |
| Munich:0JV0 | Munich | Germany | EUR |
| Frankfurt:0JV0 | Frankfurt | Germany | EUR |
| Stuttgart:0JV0 | Stuttgart | Germany | EUR |
Log in to ask 6ix AI your own questions about iBio, Inc.